These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25802090)

  • 1. Using local multiplicity to improve effect estimation from a hypothesis-generating pharmacogenetics study.
    Zou W; Ouyang H
    Pharmacogenomics J; 2016 Feb; 16(1):107-12. PubMed ID: 25802090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian model comparison in genetic association analysis: linear mixed modeling and SNP set testing.
    Wen X
    Biostatistics; 2015 Oct; 16(4):701-12. PubMed ID: 25796429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data science approaches to pharmacogenetics.
    Penrod NM; Moore JH
    Curr Mol Med; 2014; 14(7):805-13. PubMed ID: 25109795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian estimates of linkage disequilibrium.
    Sebastiani P; Abad-Grau MM
    BMC Genet; 2007 Jun; 8():36. PubMed ID: 17592642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On Latent Trait Estimation in Multidimensional Compensatory Item Response Models.
    Wang C
    Psychometrika; 2015 Jun; 80(2):428-49. PubMed ID: 24604245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shrinkage estimation of effect sizes as an alternative to hypothesis testing followed by estimation in high-dimensional biology: applications to differential gene expression.
    Montazeri Z; Yanofsky CM; Bickel DR
    Stat Appl Genet Mol Biol; 2010; 9():Article23. PubMed ID: 20597849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical Bayes correction for the Winner's Curse in genetic association studies.
    Ferguson JP; Cho JH; Yang C; Zhao H
    Genet Epidemiol; 2013 Jan; 37(1):60-8. PubMed ID: 23012258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical Bayes Gaussian likelihood estimation of exposure distributions from pooled samples in human biomonitoring.
    Li X; Kuk AY; Xu J
    Stat Med; 2014 Dec; 33(28):4999-5014. PubMed ID: 25213192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian estimation of intervention effect with pre- and post-misclassified binomial data.
    Stamey JD; Seaman JW; Young DM
    J Biopharm Stat; 2007; 17(1):93-108. PubMed ID: 17219757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Part 1. Statistical Learning Methods for the Effects of Multiple Air Pollution Constituents.
    Coull BA; Bobb JF; Wellenius GA; Kioumourtzoglou MA; Mittleman MA; Koutrakis P; Godleski JJ
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):5-50. PubMed ID: 26333238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimators of the local false discovery rate designed for small numbers of tests.
    Padilla M; Bickel DR
    Stat Appl Genet Mol Biol; 2012 Oct; 11(5):4. PubMed ID: 23079518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment effect heterogeneity for univariate subgroups in clinical trials: Shrinkage, standardization, or else.
    Varadhan R; Wang SJ
    Biom J; 2016 Jan; 58(1):133-53. PubMed ID: 26485117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correct statistical analysis of genotype frequencies for UCP and PPAR gene families in residents of besieged Leningrad and the control group].
    Khromov-Borisov NN
    Adv Gerontol; 2016; 29(3):454-460. PubMed ID: 28525693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using hierarchical modeling in genetic association studies with multiple markers: application to a case-control study of bladder cancer.
    Hung RJ; Brennan P; Malaveille C; Porru S; Donato F; Boffetta P; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1013-21. PubMed ID: 15184258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interval estimation of genetic susceptibility for retrospective case-control studies.
    Zaykin DV; Meng Z; Ghosh SK
    BMC Genet; 2004 May; 5():9. PubMed ID: 15137913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodological and statistical issues in pharmacogenomics.
    Peters BJ; Rodin AS; de Boer A; Maitland-van der Zee AH
    J Pharm Pharmacol; 2010 Feb; 62(2):161-6. PubMed ID: 20487194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some alternatives to asymptotic tests for the analysis of pharmacogenetic data using nonlinear mixed effects models.
    Bertrand J; Comets E; Chenel M; Mentré F
    Biometrics; 2012 Mar; 68(1):146-55. PubMed ID: 22049987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inference of domain-disease associations from domain-protein, protein-disease and disease-disease relationships.
    Zhang W; Coba MP; Sun F
    BMC Syst Biol; 2016 Jan; 10 Suppl 1(Suppl 1):4. PubMed ID: 26818594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criteria for the selection of single nucleotide polymorphisms in pathway pharmacogenetics: TNF inhibitors as a case study.
    Kooloos WM; Wessels JA; van der Straaten T; Huizinga TW; Guchelaar HJ
    Drug Discov Today; 2009 Sep; 14(17-18):837-44. PubMed ID: 19524701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.